机构地区:[1]河南科技大学医学院药理学与分子生物学实验室,河南洛阳471000
出 处:《中国临床药理学杂志》2016年第24期2282-2285,共4页The Chinese Journal of Clinical Pharmacology
基 金:河南省科技重点攻关基金资助项目(102102310063)
摘 要:目的研究壁虎醇提物(GEE)对H22小鼠肿瘤组织血管新生的抑制作用及其机制。方法建立腋下移植H22肝癌模型,按照体重随机分为5组:模型组(0.9%Na Cl)、对照组(2 mg·kg^(-1)阿霉素)和高、中、低3个剂量实验组(GEE:80,40,20 mg·kg^(-1)),连续腹腔注射10 d,计算抑瘤率;用免疫组化法观察血管内皮细胞标记物(CD34)表达水平,计算新生微血管密度(MVD);以免疫印迹法检测血管内皮生长因子A(VEGF-A)、基质金属蛋白酶(MMP-2)、细胞外信号调节激酶(ERK)、磷酸化的细胞外信号调节激酶(P-ERK)的表达。结果高、中、低3个剂量实验组的抑瘤率分别为63.18%,50.91%,44.68%,说明GEE对H22小鼠移植瘤的抑瘤作用较明显。模型组小鼠肿瘤组织MVD为平均每个视野(24.7±4.1)个,与模型组比较,对照组、高、中、低3个剂量实验组的MVD分别为平均每个视野(13.6±3.6),(8.0±1.6),(11.0±1.1),(13.9±1.7)个,其中3个剂量实验组差异有统计学意义(均P<0.01)。模型组、对照组、低中高3个剂量实验组的VEGF-A与β-actin灰度比值平均分别为0.17,0.10,0.01,0.03,0.04;这5组的MMP-2与β-actin灰度比值平均分别为1.68,1.27,0.48,1.15,1.50,而P-ERK与ERK灰度比值平均分别为0.10,0.07,0.06,0.07,0.08,与模型组相比,这4组差异均有统计学意义(均P<0.01),说明GEE组和对照组的VEGF-A、MMP-2、P-ERK蛋白水平均明显减弱。结论 GEE可抑制小鼠H22肝癌移植瘤的生长,其抗肿瘤作用机制可能与降低肿瘤组织血管生成相关因子VEGF-A、MMP-2、P-ERK的表达及降低微血管密度有关。Objective To investigate the inhibitory effect of Gekko etha- nol extract (GEE) on angiogenesis of H22 hepatoma and discuss its po- ssible molecular mechanism. Methods The H22 hepatoma tumor model was established by subcutaneously implanting H22 hepatoma cells into mice. The tumor - as follow : model bearing group 2 mg - kg-1), and high, mice were randomly divided into five groups ( sailing ), control group ( adriamycin, middle and low dosages experimental groups (GEE:80, 40, 20 mg - kg--) ,ten mice in each group. For 10 days of continuous intraperitoneal injection, the tumor inhibition rate was calcu- lated. The levels of a vascular endothelial cell marker (CD34) were de- tected by immunohistochemical. The microvessel density (MVD) was calculated. The expressions of vascular endothelial growth factor - A ( VEGF - A ), matrix metalloproteinase - 2 ( MMP - 2 ), extracelluar signal regulated kinase (ERK), regulating kinase phosphorylation of extracellular signals( P - ERK) were detected by Western blot. Results GEE were found to markedly inhibit the H22 mice - transplanted tumor growth. The inhibitory rate of high, middle and low dosages experimental groups were 63.18%, 50. 91% and 44.68%, respectively. For each view of model group and control group, mice tumor MVD were (24.7±4. 1 ), (13.6 ±3.6) count. Compared with model group, high, middle, low experimental groups mice tumor MVD decreased significantly(P 〈0. 01 ), for each view were (8.0 ± 1.6), ( 11.0 ± 1.1 ), ( 13.9 ± 1.7) count, respectively. Model group, control group and low, middle, high experimental groups of VEGF - A and beta actin grayscale average ratio were 0. 17,0. 10,0. 01,0. 03,0. 04. The five groups of MMP - 2 and beta actin grayscale average ratio were 1.68,1.27,0. 48,1.15,1.50. The five groups of P- ERK and ERK grayscale average ratio were 0. 10,0.07,0. 06,0. 07,0. 08. Compared to the model group, control group and three dosages experimental groups decreased significantly�
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...